Insider Transactions in Q4 2022 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2022
|
Christopher Krawtschuk Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Nov 04
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
1,263
-0.51%
|
$7,578
$6.41 P/Share
|
|
Nov 04
2022
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
218
-0.29%
|
$1,308
$6.41 P/Share
|
|
Nov 01
2022
|
Richard A Colvin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+28.57%
|
-
|
|
Oct 17
2022
|
Elisabeth Leiderman |
SELL
Open market or private sale
|
Direct |
1,004
-8.05%
|
$6,024
$6.46 P/Share
|